Dent disease is an X-linked recessive disorder of proximal tubule function, that is cause by mutations in one of the genes CLCN5 and OCRL1, Dent 1 and Dent 2 respectively. The disease is characterized clinically by low molecular weight proteinuria, nephrocalcinosis/nephrolithiasis, hypercalciuria, and progressive renal failure.
Dent disease is a rare disorder with only a few hundert cases published worldwide. However is can be surmised that many cases remain undetected because simply treated as recurrent nephrolithiasis.[Error: Macro 'ref' doesn't exist]
Low-molecular weight proteinuria is present in almost all patients with Dent disease. It is frequent in obligate female carriers even. Also female carriers may show a disposition to kidney stone formation. Based on these observations Hopes criteria were developed. The include (1) low-molecular-weight (LMW) proteinuria; (2) hypercalciuria; and (3) at least one of the following: nephrocalcinosis, kidney stones, renal insufficiency, hypophosphatemia, or hematuria.[Error: Macro 'ref' doesn't exist]
The symptom frequencies is male patients:
99% low-molecular-weight proteinuria (alpha1- and beta2-Microglobulin, Retinol binding protein)
95% hypercalciuria
75% nephrocalcinosis
50% nephrolithiasis
30-80% end-stage renal failure in the 3rd-5th decade
rickets (vitamin D metabolism)
night blindness (retinol binding)
hematuria (kidney stones)
Symptom frequencies in female patients:
In therapy, thiazide diuretics can be tried as they reduce hypercalciuria.